Literature DB >> 24794511

A quick and efficient method to generate mammalian stable cell lines based on a novel inducible alphavirus DNA/RNA layered system.

Alejandro Aranda1, Jaione Bezunartea, Erkuden Casales, Juan R Rodriguez-Madoz, Esther Larrea, Jesus Prieto, Cristian Smerdou.   

Abstract

We report a new method to generate high-expressing mammalian cell lines in a quick and efficient way. For that purpose, we developed a master cell line (MCL) containing an inducible alphavirus vector expressing GFP integrated into the genome. In the MCL, recombinant RNA levels increased >4,600-fold after induction, due to a doxycycline-dependent RNA amplification loop. The MCL maintained inducibility and expression during 50 passages, being more efficient for protein expression than a conventional cell line. To generate new cell lines, mutant LoxP sites were inserted into the MCL, allowing transgene and selection gene exchange by Cre-directed recombination, leading to quick generation of inducible cell lines expressing proteins of therapeutic interest, like human cardiotrophin-1 and oncostatin-M at several mg/l/24 h. These proteins contained posttranslational modifications, showed bioactivity, and were efficiently purified. Remarkably, this system allowed production of toxic proteins, like oncostatin-M, since cells able to express it could be grown to the desired amount before induction. These cell lines were easily adapted to growth in suspension, making this methodology very attractive for therapeutic protein production.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24794511     DOI: 10.1007/s00018-014-1631-2

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  37 in total

Review 1.  Large-scale transient expression in mammalian cells for recombinant protein production.

Authors:  F Wurm; A Bernard
Journal:  Curr Opin Biotechnol       Date:  1999-04       Impact factor: 9.740

Review 2.  Production of recombinant protein therapeutics in cultivated mammalian cells.

Authors:  Florian M Wurm
Journal:  Nat Biotechnol       Date:  2004-11       Impact factor: 54.908

3.  Role of nucleotide sequences of loxP spacer region in Cre-mediated recombination.

Authors:  G Lee; I Saito
Journal:  Gene       Date:  1998-08-17       Impact factor: 3.688

4.  In vitro and in vivo comparative study of chimeric liver-specific promoters.

Authors:  M Gabriela Kramer; Miguel Barajas; Nerea Razquin; Pedro Berraondo; Manuel Rodrigo; Catherine Wu; Cheng Qian; Puri Fortes; Jesus Prieto
Journal:  Mol Ther       Date:  2003-03       Impact factor: 11.454

Review 5.  Alphaviruses as expression vectors.

Authors:  K Lundstrom
Journal:  Curr Opin Biotechnol       Date:  1997-10       Impact factor: 9.740

Review 6.  Alphavirus vectors for cancer therapy.

Authors:  Jose I Quetglas; Marta Ruiz-Guillen; Alejandro Aranda; Erkuden Casales; Jaione Bezunartea; Cristian Smerdou
Journal:  Virus Res       Date:  2010-08-06       Impact factor: 3.303

Review 7.  The alphaviruses: gene expression, replication, and evolution.

Authors:  J H Strauss; E G Strauss
Journal:  Microbiol Rev       Date:  1994-09

8.  Mutant loxP vectors for selectable marker recycle and conditional knock-outs.

Authors:  H Arakawa; D Lodygin; J M Buerstedde
Journal:  BMC Biotechnol       Date:  2001-09-26       Impact factor: 2.563

9.  Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein.

Authors:  M D Ryan; J Drew
Journal:  EMBO J       Date:  1994-02-15       Impact factor: 11.598

10.  Mutations in the nuclear localization signal of nsP2 influencing RNA synthesis, protein expression and cytotoxicity of Semliki Forest virus.

Authors:  Kristi Tamm; Andres Merits; Inga Sarand
Journal:  J Gen Virol       Date:  2008-03       Impact factor: 3.891

View more
  3 in total

1.  1-(7-Chloroquinolin-4-yl)-N-(4-Methoxybenzyl)-5-Methyl-1H-1,2, 3-Triazole-4- carboxamide Reduces Aβ Formation and Tau Phosphorylation in Cellular Models of Alzheimer's Disease.

Authors:  Mariana G Fronza; Manoela Sacramento; Diego Alves; Domenico Praticò; Lucielli Savegnago
Journal:  Neurochem Res       Date:  2022-02-15       Impact factor: 3.996

Review 2.  Viral and Synthetic RNA Vector Technologies and Applications.

Authors:  Juliane W Schott; Michael Morgan; Melanie Galla; Axel Schambach
Journal:  Mol Ther       Date:  2016-07-05       Impact factor: 11.454

3.  Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a Syrian hamster orthotopic pancreatic cancer model.

Authors:  Estanislao Nistal-Villan; Maria Bunuales; Joanna Poutou; Manuela Gonzalez-Aparicio; Carlos Bravo-Perez; Jose I Quetglas; Beatriz Carte; Gloria Gonzalez-Aseguinolaza; Jesus Prieto; Esther Larrea; Ruben Hernandez-Alcoceba
Journal:  Mol Cancer       Date:  2015-12-16       Impact factor: 27.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.